Leukopenia, macrocytosis, and thrombocytopenia occur in young adults with Down syndrome

Gene. 2022 Aug 15:835:146663. doi: 10.1016/j.gene.2022.146663. Epub 2022 Jun 8.

Abstract

Down syndrome (DS) is a common congenital disorder caused by trisomy 21. Due to the increase in maternal age with population aging and advances in medical treatment for fatal complications in their early childhood, the prevalence and life expectancy of DS individuals have greatly increased. Despite this rise in the number of DS adults, their hematological status remains poorly examined. Here, we report that three hematological abnormalities, leukopenia, macrocytosis, and thrombocytopenia, develop as adult DS-associated features. Multi- and uni-variate analyses on hematological data collected from 51 DS and 60 control adults demonstrated that young adults with DS are at significantly higher risk of (i) myeloid-dominant leukopenia, (ii) macrocytosis characterized by high mean cell volume (MCV) of erythrocytes, and (iii) lower platelet counts than the control. Notably, these features were more pronounced with age. Further analyses on DS adults would provide a deeper understanding and novel research perspectives for multiple aging-related disorders in the general population.

Keywords: Aging; Down syndrome; Leukopenia; Macrocytosis; Thrombocytopenia.

MeSH terms

  • Child, Preschool
  • Down Syndrome* / complications
  • Hematologic Diseases*
  • Humans
  • Leukopenia* / complications
  • Thrombocytopenia*
  • Trisomy
  • Young Adult